Repare Therapeutics Inc.
RPTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$84,689 | -$93,796 | -$29,047 | -$106,908 |
| Dep. & Amort. | $1,921 | $1,951 | $1,978 | $1,471 |
| Deferred Tax | $0 | $0 | $3,620 | $149 |
| Stock-Based Comp. | $23,170 | $25,063 | $19,691 | $12,829 |
| Change in WC | -$14,057 | -$55,183 | $8,025 | $4,790 |
| Other Non-Cash | -$2,790 | -$5,193 | -$3,945 | $1,873 |
| Operating Cash Flow | -$76,445 | -$127,158 | $322 | -$85,796 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1,938 | -$602 | -$1,690 |
| Net Acquisitions | $0 | $0 | $175,176 | $40 |
| Inv. Purchases | -$133,355 | -$179,021 | -$256,576 | -$7,476 |
| Inv. Sales/Matur. | $182,823 | $259,000 | $81,400 | $7,450 |
| Other Inv. Act. | $0 | $0 | -$175,176 | $0 |
| Investing Cash Flow | $49,468 | $78,041 | -$175,778 | -$1,676 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $542 | $842 | $880 | $94,288 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1,269 |
| Financing Cash Flow | $542 | $842 | $880 | $95,557 |
| Forex Effect | -$116 | $22 | -$330 | -$54 |
| Net Chg. in Cash | -$26,551 | -$48,253 | -$174,906 | $8,031 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $111,268 | $159,521 | $334,427 | $326,396 |
| End Cash | $84,717 | $111,268 | $159,521 | $334,427 |
| Free Cash Flow | -$76,445 | -$129,096 | -$280 | -$87,486 |